Cargando…
Dexmedetomidine combined with propofol attenuates myocardial ischemia/reperfusion injury by activating the AMPK signaling pathway
OBJECTIVE: Myocardial ischemia/reperfusion (MI/R) injury is a major cause of cardiac tissue damage, with high disability and death rates. Although both dexmedetomidine (Dex) and propofol (PPF) have been indicated to alleviate MI/R injury in rat models, the effects of the combined use of these two dr...
Autores principales: | Yang, Ke, Ma, Yinhong, Xie, Chunmei, He, Lixian, Zhao, Haoxing, Dai, Zheng, Wang, Xiaoqi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10682120/ https://www.ncbi.nlm.nih.gov/pubmed/38034796 http://dx.doi.org/10.1016/j.heliyon.2023.e22054 |
Ejemplares similares
-
Dexmedetomidine attenuates myocardial ischemia-reperfusion injury in vitro by inhibiting NLRP3 Inflammasome activation
por: Huang, Yaru, et al.
Publicado: (2021) -
Dexmedetomidine reduces myocardial ischemia-reperfusion injury in young mice through MIF/AMPK/GLUT4 axis
por: Chen, Siyu, et al.
Publicado: (2022) -
Correction to: Dexmedetomidine attenuates myocardial ischemia-reperfusion injury in vitro by inhibiting NLRP3 Inflammasome activation
por: Huang, Yaru, et al.
Publicado: (2021) -
Dexmedetomidine Attenuates Myocardial Ischemia-Reperfusion Injury in Diabetes Mellitus by Inhibiting Endoplasmic Reticulum Stress
por: Li, Jinjie, et al.
Publicado: (2019) -
Curcumin attenuates myocardial ischemia–reperfusion injury
por: Liu, Kun, et al.
Publicado: (2017)